A recent INCIP study examines the oncological and obstetrical outcomes of borderline ovarian tumors and epithelial ovarian cancer diagnosed during pregnancy. The analysis of 129 cases highlights that adhering to standard oncological treatment improves survival rates and reduces relapse risk, while chemotherapy exposure during pregnancy is associated with lower birthweight.
For full details, read the study in the International Journal of Gynecological Cancer, Volume 35, Issue 2.
